Alnylam Pharmaceuticals(ALNY)
搜索文档
Alnylam Pharmaceuticals(ALNY) - 2020 Q1 - Quarterly Report
2020-05-06 20:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 001-36407 ___________________ ...
Alnylam Pharmaceuticals(ALNY) - 2019 Q4 - Annual Report
2020-02-13 21:29
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________________________ Form 10-K _____________________________________________________________________________________________ ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...
Alnylam Pharmaceuticals(ALNY) - 2019 Q4 - Earnings Call Transcript
2020-02-07 04:36
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2019 Earnings Conference Call February 6, 2020 8:30 AM ET Company Participants Christine Lindenboom - Vice President-Investor Relations and Corporate Communications John Maraganore - Chief Executive Officer Barry Greene - President Pushkal Garg - Chief Medical Officer Jeff Poulton - Chief Financial Officer Yvonne Greenstreet - Chief Operating Officer Conference Call Participants Emma Nealon - Cantor Fitzgerald & Co. Salveen Richter - Goldman Sachs David Lebowit ...
Alnylam Pharmaceuticals(ALNY) - 2019 Q3 - Quarterly Report
2019-11-01 04:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________ FORM 10-Q ____________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 001-36407 _______________ ...
Alnylam Pharmaceuticals(ALNY) - 2019 Q2 - Quarterly Report
2019-08-07 04:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 001-36407 ALNYLAM PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | --- | --- | ...
Alnylam Pharmaceuticals(ALNY) - 2019 Q1 - Quarterly Report
2019-05-03 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |-----------------------------------------------------------------------------------|-----------------------| | For the transition period from ___________ to ___________ | | | Commission ...
Alnylam Pharmaceuticals(ALNY) - 2018 Q4 - Annual Report
2019-02-15 06:25
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36407 ALNYLAM PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 77-0602661 (State or Other Jurisdiction of I ...